1. Kim, I F, Mohammadi, E, Huang, R C. . Isolation and characterization of IPP, a novel human gene encoding an actin-binding, kelch-like protein. In Gene, 228, 73-83. doi:. https://pubmed.ncbi.nlm.nih.gov/10072760/
2. Rosik, Jakub, Szostak, Bartosz, Machaj, Filip, Pawlik, Andrzej. . Potential targets of gene therapy in the treatment of heart failure. In Expert opinion on therapeutic targets, 22, 811-816. doi:10.1080/14728222.2018.1514012. https://pubmed.ncbi.nlm.nih.gov/30124081/
3. Peronnet, Estelle, Blein, Sophie, Venet, Fabienne, Brengel-Pesce, Karen, Monneret, Guillaume. 2023. Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) Study. In Critical care medicine, 51, 808-816. doi:10.1097/CCM.0000000000005832. https://pubmed.ncbi.nlm.nih.gov/36917594/
4. Huttunen, Minna M, Pekkinen, Minna, Ahlström, Mikael E B, Lamberg-Allardt, Christel J E. 2007. Effects of bioactive peptides isoleucine-proline-proline (IPP), valine-proline-proline (VPP) and leucine-lysine-proline (LKP) on gene expression of osteoblasts differentiated from human mesenchymal stem cells. In The British journal of nutrition, 98, 780-8. doi:. https://pubmed.ncbi.nlm.nih.gov/17466096/